Clinical Case Reports (Jan 2024)

Negative myoclonus as a manifestation of cefepime neurotoxicity

  • Daichi Umemoto,
  • Hirokazu Kuroda,
  • Hiroaki Nishioka

DOI
https://doi.org/10.1002/ccr3.8380
Journal volume & issue
Vol. 12, no. 1
pp. n/a – n/a

Abstract

Read online

Key Clinical Message Negative myoclonus may present in the early stages of cefepime neurotoxicity. Cefepime neurotoxicity typically presents as reduced consciousness, myoclonus, and seizures; however, negative myoclonus is uncommon. This video shows an older woman with cefepime neurotoxicity that presented as a negative myoclonus of the upper limbs.

Keywords